Post-procedure protection is more than a recommendation—it is a clinical requirement.
Following laser resurfacing, microneedling, chemical peels, IPL, or injectable treatments, the skin becomes significantly more vulnerable to UV radiation and environmental stressors.
Mineral Complexions™ Post-Procedure Shield SPF30 was developed specifically for this scenario.
Clinical Advantages
- High-purity zinc oxide (25%) for broad-spectrum protection
- Non-nano, non-comedogenic formula suitable for sensitive skin
- Water/sweat resistance (40 minutes) for active lifestyles
- Balanced texture that blends evenly without leaving white residue
- Vegan, gluten-free, fragrance-free formulation
Designed for Professional Environments
Clinics require consistency and reliability.
Our formulation has undergone:
- stability testing
- shade uniformity validation
- microbial testing
- packaging compatibility assessments
Optimized for Patient Outcomes
With its high zinc concentration and skin-friendly formulation, Mineral Complexions™ supports improved recovery, comfort, and compliance following aesthetic treatments.
Clinicians and patients gain peace of mind knowing every bottle is authenticated, traceable, and backed by a scientific development process designed for professional use.
Vanessa I.
President
Cosmectology Enterprises Inc.
president@cosmectology.com
Related reading
Author
Vanessa I. is the President of Cosmectology Enterprises Inc., a Canadian innovation company specializing in medical-grade dermatology products and advanced digital traceability. With more than a decade of experience in clinical operations, product oversight, and business leadership, she directs CEI’s strategy across R&D, regulatory compliance, manufacturing, and global market expansion. Under her leadership, CEI secured Health Canada approval for its flagship Mineral Complexions™ Post-Procedure Face Shield SPF30 and deployed a secure QR/NFC authentication system that strengthens product safety, export compliance, and clinic-level verification. Vanessa I. also oversees CEI’s ESG and sustainability initiatives, guides the company’s R&D pipeline for next-generation dermatological innovations, and leads expansion into U.S. and European markets. Her women-led leadership ensures CEI remains aligned with Canada’s innovation programs, export pathways, and clinical standards while advancing long-term international growth. Contact: president@cosmectology.com
